Targeting KCC2 and NKCC1 for spinal motor dysfunction: pharmacology, therapeutic opportunities, and translational roadmap. // Pharmacology & Therapeutics. – URL: https://www.sciencedirect.com/science/article/pii/S0163725826001567?dgcid=rss_sd_all
Targeting KCC2 and NKCC1 for spinal motor dysfunction: pharmacology, therapeutic opportunities, and translational roadmap. Pharmacology & Therapeutics. https://www.sciencedirect.com/science/article/pii/S0163725826001567?dgcid=rss_sd_all
“Targeting KCC2 and NKCC1 for spinal motor dysfunction: pharmacology, therapeutic opportunities, and translational roadmap.” Pharmacology & Therapeutics.
@article{article62101,
title = {Targeting KCC2 and NKCC1 for spinal motor dysfunction: pharmacology, therapeutic opportunities, and translational roadmap},
journal = {Pharmacology \& Therapeutics},
url = {https://www.sciencedirect.com/science/article/pii/S0163725826001567?dgcid=rss_sd_all}
}